1.A Validated Tool for Psychiatric Comorbidity in the Patients With Functional Dyspepsia: Author's Reply
Larry H LAI ; Ada WY TSE ; Justin CY WU
Journal of Neurogastroenterology and Motility 2010;16(3):339-339
No abstract available.
Comorbidity
;
Humans
2.A Validated Tool for Psychiatric Comorbidity in the Patients With Functional Dyspepsia
Journal of Neurogastroenterology and Motility 2010;16(2):221-221
No abstract available.
Comorbidity
;
Dyspepsia
;
Humans
3.Rhinitis and Asthma Comorbidity
Journal of Asthma, Allergy and Clinical Immunology 2009;29(4):227-233
4.Rhinitis and Asthma Comorbidity
Journal of Asthma, Allergy and Clinical Immunology 2009;29(4):227-233
5.Rhinitis and Asthma Comorbidity
Journal of Asthma, Allergy and Clinical Immunology 2009;29(4):227-233
6.Rhinitis and Asthma Comorbidity
Journal of Asthma, Allergy and Clinical Immunology 2009;29(4):227-233
7.Medical Comorbidities and the Onset of Androgenetic Alopecia: A Population-Based, Case-Control Study.
Hee Chul CHUNG ; Sung Jay CHOE ; Solam LEE ; Sung Soo OH ; Won Soo LEE
Annals of Dermatology 2018;30(2):251-252
No abstract available.
Alopecia*
;
Case-Control Studies*
;
Comorbidity*
8.Korean Standardization of General Medical Health Rating on Dementia Patients.
Seong Su JEONG ; Yong Jae SHIN ; Jung Ae AHN ; Kyoung Hee YEO ; Suk Chul SHIN
Journal of Korean Geriatric Psychiatry 2000;4(2):164-172
Concurrent medical problem is common in dementia patients and critical to their care. Despite its importance, there was no bedside global rating scale for the seriousness of medical comorbidity. Lykestos et al. newly developed a reliable bedside scale, the General Medical Health Rating(GMHR). The objective of this study was to standardize the GMHR in form of Korean version(KGMHR). The study population consisted of 35 dementia patients in nursing home. Rating was performed by 1 physician and 2 nurses. Forty percent(14/35) of patients had one or more unstable medical illnesses. KGMHR ratings no more than 3 were 71.5%(25/35) of patients. The value of interrater reliability coefficient alpha was 0.9121. Correlations between KGMHR ratings and number of unstable medi-cal illnesses were high(r=-0.487, p<0.01). KGMHR ratings were also correlated with number of medications being taken for comorbid conditions(r=-0.542, p<0.01). In conclusion, KGMHR is a very reliable and simple rating scale for medical comorbidity in dementia patients. So the KGMHR could be a useful tool for evaluation of comorbidity in dementia patients. To verify the prognostic value of KGMHR, further large sized long-term study are needed.
Comorbidity
;
Dementia*
;
Humans
;
Nursing Homes
9.Tuberculosis Treatment in Patients with Comorbidities.
Tuberculosis and Respiratory Diseases 2014;76(6):257-260
Tuberculosis is a significant infectious problem in elderly patients with comorbidities in Korea. The age-associated diseases such as malignancy and diabetes mellitus may increase the risk of tuberculosis in this population. The medication treatments of tuberculosis in patients with comorbidities can cause adverse reactions to antituberculosis drugs and inadequate treatment responses. Thus, clinicians must carefully monitor the toxicity of antituberculosis therapy and the efficacy of treatment in patients with comorbidities.
Aged
;
Comorbidity*
;
Diabetes Mellitus
;
Humans
;
Korea
;
Tuberculosis*
10.Cognitive impairment in childhood onset epilepsy: up-to-date information about its causes.
Korean Journal of Pediatrics 2016;59(4):155-164
Cognitive impairment associated with childhood-onset epilepsy is an important consequence in the developing brain owing to its negative effects on neurodevelopmental and social outcomes. While the cause of cognitive impairment in epilepsy appears to be multifactorial, epilepsy-related factors such as type of epilepsy and underlying etiology, age at onset, frequency of seizures, duration of epilepsy, and its treatment are considered important. In recent studies, antecedent cognitive impairment before the first recognized seizure and microstructural and functional alteration of the brain at onset of epilepsy suggest the presence of a common neurobiological mechanism between epilepsy and cognitive comorbidity. However, the overall impact of cognitive comorbidity in children with epilepsy and the independent contribution of each of these factors to cognitive impairment have not been clearly delineated. This review article focuses on the significant contributors to cognitive impairment in children with epilepsy.
Brain
;
Child
;
Cognition
;
Comorbidity
;
Epilepsy*
;
Humans
;
Seizures